RECENT WEBINARS
How Intensified Upstream Processing Improves Scale-Up And Tech Transfer
Intensified upstream processing can improve scalability and maintain quality. Learn how automation, PAT, and data-driven control strategies help modernize workflows and support consistent performance.
Generate Stable High-Producing Clones In 14 Weeks
Rising complexity is putting pressure on cell line development. Discover a streamlined approach that enables rapid generation of stable clones with strong titers and long-term consistency.
Creative Chromatography Solutions For Complex Small Molecules
Chromatographic modeling enables smarter purification. Discover how digital tools, fraction mapping, and expert execution can improve yield for the most challenging small-molecule separations.
Using Residual DNA Quantification Data To De-Risk mAb Development
Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.
Viral Safety Testing In Biologics: Detecting What Current Methods Miss
Biologics face unpredictable risks as complexity grows; evolving testing strategies to broaden detection, address gaps, and strengthen safety confidence without disrupting development or compliance.
Cracking Complexity: Learnings From 70+ Bispecific Antibody Programs
The goal is practical: help development teams make early decisions that balance speed, quality, and risk and support a smoother path to the clinic.
From Gene Editing To NGS-Based T Cell Characterization
Gene-edited T cells targeting PD-1 and TIGIT are redefining approaches to cancer therapy. Explore how cell engineering and integrated genomic workflows uncover critical insights into T cell function.
Efficient mAb Development With A Flexible Purification Toolkit
Increasing mAb complexity is pushing purification beyond traditional platforms. See how flexible chromatography, optimized buffers, and adaptable workflows are becoming essential to achieve target purity.
Faster Clones, Simpler Process: What's Changing In CHO Expression?
This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.
How Solid-State Science Solves Your Toughest API Challenges
Difficult small molecules demand more than standard purification strategies. See how combining solid-state expertise with advanced chromatographic modeling improves filtration, purity, and scalability.
From Complexity To Confidence: Supporting Tech Transfer With A Prefillable Syringe System
Discover how aligning packaging strategy with technology transfer requirements can accelerate timelines, control costs, and support successful injectable drug product manufacturing.
Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing
See how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.
CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic
As CAR-T advances, shifting clinical progress and market dynamics are reshaping development strategies. Explore how evolving therapies and operational demands are redefining the next wave of innovation.
Real-Time DAR And Concentration Measurement Without Dilution
Maintaining consistent DAR while reducing risk and variability remains a major ADC challenge. Learn how real‑time spectroscopy replaces dilution‑heavy workflows and strengthens process control.
Advancing Therapeutic Discovery With High-Throughput Electroporation
Learn how high-throughput electroporation streamlines genetic material delivery for cell therapy and drug discovery, offering speed, precision, and scalability across hard-to-transfect cell types.
The Framework For Containment In A Cleanroom
ISO classification decisions shape cleanroom design. Learn how early alignment between process needs, biosafety, and classification can reduce redesign risk while supporting scalable environments.
How Iteration And Operational Readiness Accelerate Product-To-Patient
See how an iterative, risk‑based approach to Commissioning & Qualification shifts verification earlier, reduces late‑stage pressure, and supports smoother startups through operational readiness.
Understanding The Regulatory Landscape For Ophthalmic Drug Products
Learn how evolving ophthalmic regulations, contamination control strategies, and advanced packaging solutions can help support compliance, product quality, and patient safety.
Strategic Early Material Generation For Accelerated Process Development
Learn how early material generation strategies can accelerate biologics development, streamline process optimization, and enable scalable, production-relevant material supply from the earliest stages of development.
Design Scalable Downstream Processes With Practical Strategies
Downstream purification is becoming more complex as new modalities enter development. Learn how advanced analytics and chromatography strategies can support scalable, confident process development.
From Insights To Impact: Predictive Models And PAT For More Efficient And Robust Biologics Manufacturing
Explore how advanced scale-up methodologies and real-time analytical technologies strengthen both drug substance and drug product manufacturing by enabling process understanding and informed decision-making.
How To Activate AI Under GxP, Governance, And Security Constraints
AI insights are abundant in pharma, but action requires trust. Learn how governed, validated Industrial AI can move beyond advisory analytics to support compliant, auditable decisions.
Early Developability Assessment For Antibody Based Therapeutics
Learn how an integrated developability and immunosafety toolbox can help de-risk multi-specific antibody development, improve candidate selection, and accelerate complex biologics toward the clinic.
Comprehensive Bioprocess Control: Substrate, Metabolite And Product Analysis
Explore how multi-parameter bioprocess analyzers support monitoring of 30+ bioprocess parameters across mammalian and microbial systems to optimize yield and product quality.
3 Critical UF/DF Challenges And How To Solve Them
High‑concentration mAbs change how UF/DF behaves. Learn how modern TFF platforms help address these challenges and maintain control as formulations move beyond traditional limits.
How Connected Digital Execution Turns Pharma Data Into Decisions
Disconnected systems slow investigations and delay batch release. Learn how a digitally connected execution ecosystem provides real-time context for alerts, enabling proactive control and faster decisions.
Engineering Precision In Genetic Medicines
Precision genome editing strategies that balance specificity and potency through advanced engineering workflows, AI‑driven optimization, and tailored editor design for clinical genetic medicines.
From DNA To IND In As Little As 6 Months
Discover how an integrated, platform-driven CMC approach can accelerate your antibody program from DNA to IND in as little as six months while reducing risk and maintaining quality and regulatory alignment.
Biologics Tech Transfer & Validation at Scale: A Better Path to GMP
Explore where tech transfer and validation commonly falter, and how disciplined execution helps teams maintain control through PPQ and beyond.